Monopar raises IPO Target to $46 Million

Monopar raises IPO Target to $46 Million

Submitted by admin on September 11, 2019 - 9:57am
Source: 
CP Wire
News Tags: 
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Headline: 
Monopar raises IPO Target to $46 Million
snippet: 

Monopar filed an amendment to its IPO filing on 9/10/19. It has raised its upper estimate to $46 Million. The company will trade on NASDAQ under the symbol, “MNPR.” See original article here.

Do Not Allow Advertisers to Use My Personal information